Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Twist Bioscience Corp | Director | Common Stock | 23K | $800K | $34.76 | Nov 21, 2022 | Direct |
REPLIGEN CORP | Director | Common Stock | 4.67K | $586K | $125.45 | Jun 14, 2024 | Direct |
STANDARD BIOTOOLS INC. | Director | Common Stock | 204K | $518K | $2.54 | Apr 1, 2022 | The Barthelemy 2001 Trust |
908 Devices Inc. | Director | Common Stock, par value $0.001 | 15.4K | $186K | $12.08 | Jun 15, 2022 | Direct |
908 Devices Inc. | Director | Common Stock, par value $0.001 | 13.5K | $164K | $12.08 | Jun 15, 2022 | Indirect |
Twist Bioscience Corp | Director | Director Stock Option (right to buy) | 11.3K | Nov 21, 2022 | Direct | ||
REPLIGEN CORP | Director | Stock Option (Right to Buy) | 1.38K | May 16, 2024 | Direct | ||
908 Devices Inc. | Director | Restricted Stock Unit | 0 | Jun 15, 2022 | Direct | ||
STANDARD BIOTOOLS INC. | Director | Stock Option (Right to Buy) | 0 | $3.74 | Apr 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RGEN | REPLIGEN CORP | Jun 14, 2024 | 1 | $151K | 4 | Jun 14, 2024 | Director |
RGEN | REPLIGEN CORP | May 16, 2024 | 2 | $0 | 4 | May 20, 2024 | Director |
RGEN | REPLIGEN CORP | May 18, 2023 | 2 | $0 | 4 | May 22, 2023 | Director |
TWST | Twist Bioscience Corp | Nov 21, 2022 | 2 | $212K | 4 | Nov 23, 2022 | Director |
MASS | 908 Devices Inc. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
RGEN | REPLIGEN CORP | May 26, 2022 | 2 | $0 | 4 | May 31, 2022 | Director |
TWST | Twist Bioscience Corp | May 11, 2022 | 1 | $250K | 4 | May 13, 2022 | Director |
LAB | STANDARD BIOTOOLS INC. | Apr 1, 2022 | 2 | $0 | 4 | Apr 4, 2022 | Director |
LAB | STANDARD BIOTOOLS INC. | Mar 31, 2022 | 2 | $0 | 4 | Apr 1, 2022 | Director |
TWST | Twist Bioscience Corp | Feb 8, 2022 | 1 | $0 | 4 | Feb 10, 2022 | Director |
RGEN | REPLIGEN CORP | Oct 29, 2021 | 4 | -$309K | 4 | Nov 2, 2021 | Director |
MASS | 908 Devices Inc. | Jun 23, 2021 | 7 | -$505K | 4 | Jun 25, 2021 | VP, Corporate Development, Director |
MASS | 908 Devices Inc. | Jun 17, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director |
LAB | FLUIDIGM CORP | May 25, 2021 | 2 | $0 | 4 | May 27, 2021 | Director |
RGEN | REPLIGEN CORP | May 13, 2021 | 2 | $0 | 4 | May 17, 2021 | Director |